Karad Neonatal And Pediatric Intensive Care Unit Limite Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
- Paid Up Capital ₹ 3.35 M
- Company Age 25 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 11.02%
- Profit Growth 225.18%
- Ebitda 56.66%
- Net Worth 33.40%
- Total Assets 13.61%
About Karad Neonatal And Pediatric Intensive Care Unit Limite
Karad Neonatal And Pediatric Intensive Care Unit Private Limite (KNAPICUPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 October 1999 and has a history of 25 years and three months. Its registered office is in Satara, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.35 M, as per Ministry of Corporate Affairs (MCA) records.
Rajiv Bahulekar, Rajesh Vitthal, Kshama Jadhav, and Six other members serve as directors at the Company.
Company Details
-
Location
Satara, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85110PN1999PTC014085
-
Company No.
014085
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Oct 1999
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Karad Neonatal And Pediatric Intensive Care Unit Limite?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Lahoti
|
Managing Director | 18-Oct-1999 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Dilip Vitthal
|
Director | 18-Oct-1999 | Current |
|
Rajiv Bahulekar
|
Director | 18-Oct-1999 | Current |
|
Rajesh Vitthal
|
Director | 18-Oct-1999 | Current |
|
Kshama Jadhav
|
Director | 18-Oct-1999 | Current |
|
Girish Joag
|
Director | 18-Oct-1999 | Current |
|
Arvind Walimbe
|
Director | 18-Oct-1999 | Current |
Financial Performance of Karad Neonatal And Pediatric Intensive Care Unit Limite.
Karad Neonatal And Pediatric Intensive Care Unit Private Limite, for the financial year ended 2019, experienced significant growth in revenue, with a 11.02% increase. The company also saw a substantial improvement in profitability, with a 225.18% increase in profit. The company's net worth Soared by an impressive increase of 33.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Karad Neonatal And Pediatric Intensive Care Unit Limite?
In 2017, Karad Neonatal And Pediatric Intensive Care Unit Limite had a promoter holding of 98.65% and a public holding of 1.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Karad Neonatal And Pediatric Intensive Care Unit Limite?
Unlock and access historical data on people associated with Karad Neonatal And Pediatric Intensive Care Unit Limite, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Karad Neonatal And Pediatric Intensive Care Unit Limite, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karad Neonatal And Pediatric Intensive Care Unit Limite's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
